|
|
Rm-615, AIOS Meguro-Ekimae, 2-15-19, Kami-Osaki, Shinagawa-ku
Tokyo, 141-0021 Japan
phone:+81-3-3280-6057
fax:+81-3-3280-6058
|
|
| Symbol |
Private |
| Founded |
2002 |
| Employees |
|
|
|
| www.aphoenix.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Chemical genomics company |
|
| Management |
| Shingo Kano, Ph.D., President and CEO, Chairman; Yasuhiro Chigira, Ph.D. Director; Takeo Matsumoto, Ph.D. Director |
| |
|
|
| |
|
| Keywords |
| chromatographic, pharmaceutical, therapeutics, respiratory, inflammatory |
|
|
|
| Description |
|
They exploit drugs which lack known mechanisms of action as probes for discovering novel druggable targets, and then develop the compounds against these validated targets. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members